AGIO Agios Pharmaceuticals Inc

Agios Pharmaceuticals Inc is a biopharmaceutical company which focuses on developing treatments geared towards cancer and rare genetic disorders of metabolism. It also emphasizes on developing potentially transformative small-molecule medicines.

$20.00  -1.09 (-5.17%)
As of 05/24/2022 10:57:57 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  07/24/2013
Outstanding shares:  54,788,927
Average volume:  687,379
Market cap:   $1,156,046,360
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BCBVTX1
Valuation   (See tab for details)
PE ratio:   -6.10
PB ratio:   0.96
PS ratio:   0.00
Return on equity:   -30.18%
Net income %:   -43,793.97%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy